Cargando…
Rituximab biosimilars open new horizons in immunotherapy
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703380/ https://www.ncbi.nlm.nih.gov/pubmed/29209531 http://dx.doi.org/10.1136/esmoopen-2017-000234 |
| _version_ | 1783281670026166272 |
|---|---|
| author | Jaeger, Ulrich |
| author_facet | Jaeger, Ulrich |
| author_sort | Jaeger, Ulrich |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5703380 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57033802017-12-05 Rituximab biosimilars open new horizons in immunotherapy Jaeger, Ulrich ESMO Open Editorial BMJ Publishing Group 2017-08-04 /pmc/articles/PMC5703380/ /pubmed/29209531 http://dx.doi.org/10.1136/esmoopen-2017-000234 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Editorial Jaeger, Ulrich Rituximab biosimilars open new horizons in immunotherapy |
| title | Rituximab biosimilars open new horizons in immunotherapy |
| title_full | Rituximab biosimilars open new horizons in immunotherapy |
| title_fullStr | Rituximab biosimilars open new horizons in immunotherapy |
| title_full_unstemmed | Rituximab biosimilars open new horizons in immunotherapy |
| title_short | Rituximab biosimilars open new horizons in immunotherapy |
| title_sort | rituximab biosimilars open new horizons in immunotherapy |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703380/ https://www.ncbi.nlm.nih.gov/pubmed/29209531 http://dx.doi.org/10.1136/esmoopen-2017-000234 |
| work_keys_str_mv | AT jaegerulrich rituximabbiosimilarsopennewhorizonsinimmunotherapy |